Profile image
Story Views

Last Hour:
Last 24 Hours:

Low Back Pain Pipeline Review, H2 2016: Therapeutics Analysis by Stage of Development, Drug Target, MoA, RoA & Molecule Type

Monday, November 14, 2016 3:23
% of readers think this story is Fact. Add your two cents.

Latest Low Back Pain Pipeline Review, H2 2016, provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.

Low Back Pain therapeutics industry report provides comprehensive information on the therapeutics under development for Low Back Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects.

Browse more detail information about Low Back Pain market report at:


Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key players in Low Back Pain – Pipeline Review, H2 2016:

  • Adynxx, Inc.
  • Aestus Therapeutics, Inc.
  • Array BioPharma Inc.
  • Axsome Therapeutics Inc
  • Boehringer Ingelheim GmbH
  • Egalet Corporation
  • Frontier Biotechnologies Co., Ltd
  • Gador S.A.
  • Grunenthal GmbH

Get a PDF Sample of Low Back Pain Market Research Report at:

Drug Profiles of Included in Low Back Pain Therapeutics Development Market Report

  • (loxoprofen + methocarbamol)
  • AB-001
  • ATX-09002
  • bupivacaine

And other drug profiles

Have any query? ask our expert @

Key Topics Covered:
2.Low Back Pain Overview
3.Low Back Pain Therapeutics Development
4.Pipeline Products for Low Back Pain – Overview
5.Pipeline Products for Low Back Pain – Comparative Analysis
6.Low Back Pain – Therapeutics under Development by Companies
7.Low Back Pain – Therapeutics under Investigation by Universities/Institutes
8.Low Back Pain Products Glance
9.Late Stage Products
10.Clinical Stage Products
11.Early Stage Products
12.Low Back Pain – Products under Development by Companies
13.Low Back Pain – Products under Investigation by Universities/Institutes
14.Low Back Pain – Companies Involved in Therapeutics Development
15.Low Back Pain Drug Profiles
16.Low Back Pain Dormant Projects
17.Low Back Pain Discontinued Products
18.Low Back Pain Featured News & Press Releases
And Continue…

Get Discount on Low Back Pain Market Research Report at:

This research study help to:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Low Back Pain
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Low Back Pain pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.


Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email –

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.